Lars Bastholt
Odense University Hospital(DK)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Cutaneous Melanoma Detection and Management, Melanoma and MAPK Pathways, CAR-T cell therapy research, Thyroid Cancer Diagnosis and Treatment
Most-Cited Works
- → Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma(2015)8,055 cited
- → Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma(2019)3,642 cited
- → Tertiary lymphoid structures improve immunotherapy and survival in melanoma(2020)2,253 cited
- → Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial(2014)1,610 cited
- → Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy(2016)1,305 cited
- → Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial(2003)671 cited